These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3493371)

  • 21. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia.
    Marshall RC; Huang SC; Nash WW; Phelps ME
    J Nucl Med; 1983 Nov; 24(11):1060-4. PubMed ID: 6631527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 25. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Schelbert HR
    J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 27. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limitations of myocardial FDG studies.
    McFalls EO
    Circulation; 1995 Nov; 92(10):3145. PubMed ID: 7586289
    [No Abstract]   [Full Text] [Related]  

  • 29. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
    Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME
    J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future directions for clinical investigation of the heart with positron-emission tomography.
    Selwyn AP; Smith TW
    Circulation; 1985 Nov; 72(5 Pt 2):IV31-8. PubMed ID: 3876892
    [No Abstract]   [Full Text] [Related]  

  • 31. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G; Schwaiger M
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract]   [Full Text] [Related]  

  • 32. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
    Ashmarin IIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):103-7. PubMed ID: 6391515
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT].
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H
    J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are the irreversible perfusion defects on myocardial thallium scans really irreversible?
    Schelbert HR
    Eur Heart J; 1988 Apr; 9 Suppl F():23-8. PubMed ID: 3391182
    [No Abstract]   [Full Text] [Related]  

  • 37. [Positron computed tomography: a new method for quantitative determination of cardiac metabolism, blood circulation and function. I. Technical and experimental bases].
    Schön HR; Schelbert HR; Phelps ME
    Nuklearmedizin; 1983 Aug; 22(4):171-80. PubMed ID: 6356039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
    J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction.
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Nohara R; Tamaki N; Yonekura Y; Senda M; Konishi J; Kawai C
    Am J Cardiol; 1988 Jun; 61(15):1191-7. PubMed ID: 3259830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET].
    Adams S; Baum RP; Scholz M; Zeiher AM; Hör G
    Nuklearmedizin; 1997 Jun; 36(4):146-9. PubMed ID: 9289701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.